Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Study to Compare CDB-2914 and Levonorgestrel-275993302
New York University Medical Ce
Search grants from New York University Medical Ce
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Ciliary trafficking mechanisms underlying the human genetics of obesity
Activity-dependent modulation of the Drosophila mushroom body function by FMRP
Internet-based Fidelity Enhancement of MTFC
Generating HIV resistant cells from conditionally transformed HSC cell lines
Compiler Infrastructure: The SUIF Compiler Infrastructure
Recently added grants:
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
Tumor-selective use of PARP inhibitors against NQO1+ nonsmall cell lung cancer
Effect of GABAergic inhibition of dendritic spines on synaptic pruning in the medial prefrontal cortex during adolescence
Novel therapeutic approaches for traumatic brain injury induced cognitive deficits
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD093302-011
Application #
6829064
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
New York University Medical Ce
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 HD
Phase II Study to Compare CDB-2914 and Levonorgestrel-275993302
/ New York University Medical Ce
NIH 1999
N01 HD
Phase II Study to Compare CDB-2914 and Levonorgestrel
Wan, Livia / New York University
NIH 1999
N01 HD
Phase II Study to Compare CDB-2914 and Levonorgestrel
Wan, Livia / New York University
Comments
Be the first to comment on this grant